The Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract to Amerisourcebergen Drug Corp on December 17, 2022. With a potential value of $9.999 billion and a period of performance through December 31, 2031, this contract will support the Defense Health Agency's TRICARE Pharmacy Program.
Under the contract, Amerisourcebergen Drug Corp will replenish pharmaceutical and related products to multiple TRICARE pharmacy ordering facilities across the continental United States. The contractor will also provide readiness support and serve as the backup provider to other pharmaceutical prime vendors servicing these ordering sites. Additionally, Amerisourcebergen Drug Corp will integrate its fulfillment operations with the Defense Health Agency's separate TRICARE Pharmacy Program 5 contract to ensure beneficiaries receive necessary medications. Pricing will be determined using Federal Supply Schedule, DAPA, or regional DAPA rates plus the contractor's distribution and cost recovery fees.
The originating solicitation sought industry feedback on performance requirements for the National Prime Vendor Generation IV contract. Per the Special Notice, the draft Statement of Work outlined replenishing up to 12 pharmacy ordering facilities for a base period and optional additional year not exceeding five years total. Responses were requested by July 24, 2020 to aid finalizing the contract's terms.